Protara Therapeutics, Inc Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition
Protara Therapeutics, Inc. announced that it has reached alignment with the U.S. Food and Drug Administration on a registrational path forward for intravenous Choline Chloride, an investigational...
Source: marketscreener.com